Thermo Fisher

Thermo Fisher Scientific to acquire Patheon

Tuesday, May 16, 2017

Thermo Fisher Scientific will acquire Patheon, a global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors. Thermo Fisher will commence a tender offer to acquire all of the issued and outstanding shares of Patheon for $35 per share in cash. The transaction represents a purchase price of approximately $7.2 billion, which includes the assumption of approximately $2 billion of net debt.

[Read More]

Thermo Fisher Scientific, Cell and Gene Therapy Catapult collaborate

Tuesday, March 21, 2017

To help address the challenges surrounding supply chain management for cell and gene therapy around the globe, Thermo Fisher Scientific announced a collaboration with the Cell and Gene Therapy Catapult (CGT Catapult) to provide developers with both the manufacturing capability and distribution, logistics and storage capacity needed to create a seamless supply chain to accelerate cell and gene therapy development and commercialization.

[Read More]

Thermo Fisher Scientific launches new Pharmacoscan solution

Monday, October 17, 2016

To meet the growing demand for preemptive pharmacogenomic risk factor screening that may one day aid drug prescription practices, Thermo Fisher Scientific has introduced PharmacoScan Solution, a new microarray-based research tool that contains pharmacogenomic content with relevant markers involved in absorption, distribution, metabolism and excretion (ADME) pathways of commonly prescribed medicines.

[Read More]

Thermo Fisher Scientific opens new clinical services facility in South Korea

Monday, September 12, 2016

To address the growing global demand for clinical services, Thermo Fisher Scientific has announced the official opening of its new state-of-the-art GMP1 standard facility in South Korea. Strategically located in Seoul, the new site will provide local, regional and global pharmaceutical and biotech companies with a one-stop service for clinical supplies—from cGMP storage, local labelling, secondary packaging, comparator sourcing, handling and distribution of ambient and cold chain supplies to clinical site returns management.

[Read More]